Is nuchal translucency of 3.0-3.4 mm an indication for cfDNA testing or microarray? - a multicenter retrospective clinical cohort study.
Rybak-Krzyszkowska M, Madetko-Talowska A, Szewczyk K, Bik-Multanowski M, Sakowicz A, Stejskal D, Trková M, Smetanová D, Serafim S, Correia H, Nevado J, Angeles Mori M, Mansilla E, Rutkowska L, Kucińska A, Gach A, Huras H, Kołak M, Srebniak MI.
Rybak-Krzyszkowska M, et al. Among authors: szewczyk k.
Fetal Diagn Ther. 2024 May 30. doi: 10.1159/000539463. Online ahead of print.
Fetal Diagn Ther. 2024.
PMID: 38815555